# Vitamin D Supplementation for Extremely Preterm Infants

> **NCT01600430** · PHASE2,PHASE3 · COMPLETED · sponsor: **University of Alabama at Birmingham** · enrollment: 100 (actual)

## Conditions studied

- Vitamin D Deficiency
- Preterm Infants
- Bronchopulmonary Dysplasia

## Interventions

- **DIETARY_SUPPLEMENT:** Cholecalciferol
- **DIETARY_SUPPLEMENT:** Cholecalciferol
- **DIETARY_SUPPLEMENT:** Placebo

## Key facts

- **NCT ID:** NCT01600430
- **Lead sponsor:** University of Alabama at Birmingham
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-06
- **Primary completion:** 2014-12
- **Final completion:** 2016-12
- **Target enrollment:** 100 (ACTUAL)
- **Last updated:** 2017-02-10

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01600430

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01600430, "Vitamin D Supplementation for Extremely Preterm Infants". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT01600430. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*